New York, NY -- (SBWIRE) -- 12/06/2013 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today We bring special trend analysis of following stocks: Federal Home Loan Mortgage Corp(OTCBB:FMCC) Buka Ventures Inc(OTCBB:NNRX), Ford Motor Company(NYSE:F), Geron Corporation(NASDAQ:GERN)
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
Federal Home Loan Mortgage Corp(OTCBB:FMCC) increased +0.40% at the price of $2.49 recently on a traded volume of 2.47million shares, in comparison to 15.37 million shares of average trading volume. So far this year, the stock is over +846.77%.
The company has a total market capitalization of $1.63 Billion and its total outstanding shares are 650.04 million.
For How Long FMCC will Fight for Profitability? Read This Trend Analysis report
Buka Ventures Inc(OTCBB:NNRX) soared +3.51% at the trading price of $1.18on a traded volume of 1.40 million shares till now, whereas its average trading volume is 1.63 million shares. In the last three months, the stock is up +57.33%. The Intra-day range for the stock is $1.13 and $1.18.
For How Long NNRX’s Gloss will Attract Investors? Find out via this report
Ford Motor Company(NYSE:F) dropped down -0.60% at the $16.64 recently. So far in three months, the stock is down -2.06%. The 52-week range for the stock is $11.03 and $18.02 Its introductory price for the day was $16.92, with the overall traded volume of 11.95 million shares. Ford Motor Company (Ford) is a producer of automobiles. The Company together with its subsidiaries is engaged in other businesses, including financing vehicles.
Why Should Investors Buy F After the Recent Fall? Just Go Here and Find Out
Geron Corporation(NASDAQ:GERN), after opening its shares at the price of $6.72, dropped -0.17% , its recent trading price was $5.85 for the day. The stock moved on a traded volume of 11.14 million shares, in comparison to 6.11 million shares of average trading volume.
The 52-week range for the stock is $0.98 and $7.79. Its introductory price for the day was $6.72. Geron Corporation (Geron) is a clinical-stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Will GERN Get Buyers Even After The Recent Rally? Find Out Here
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)